The role of genetic risk factors of Alzheimer's disease in synaptic dysfunction

被引:19
作者
Fu, Wing-Yu [1 ,2 ]
Ip, Nancy Y. [1 ,2 ,3 ]
机构
[1] Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Div Life Sci, State Key Lab Mol Neurosci,Clear Water Bay,Kowloon, Hong Kong, Peoples R China
[2] Hong Kong Ctr Neurodegenerat Dis, Hong Kong Sci Pk, Hong Kong, Peoples R China
[3] Shenzhen Hong Kong Inst Brain Sci, HKUST Shenzhen Res Inst, Guangdong Prov Key Lab Brain Sci Dis & Drug Dev, Shenzhen 518057, Guangdong, Peoples R China
关键词
Synapses; Genetic risks; Synaptic vesicles; Neurotransmitter release; Neurotransmission; Synaptic plasticity; Protein trafficking; GENOME-WIDE ASSOCIATION; APOE GENOTYPE; RECEPTOR FUNCTION; PROTEIN CD2AP; PLASTICITY; ADAM10; TREM2; BETA; PHOSPHORYLATION; MUTATIONS;
D O I
10.1016/j.semcdb.2022.07.011
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Alzheimer's disease (AD) is a neurodegenerative disease characterized by the progressive deterioration of cognitive functions. Due to the extended global life expectancy, the prevalence of AD is increasing among aging populations worldwide. While AD is a multifactorial disease, synaptic dysfunction is one of the major neuro-pathological changes that occur early in AD, before clinical symptoms appear, and is associated with the pro-gression of cognitive deterioration. However, the underlying pathological mechanisms leading to this synaptic dysfunction remains unclear. Recent large-scale genomic analyses have identified more than 40 genetic risk factors that are associated with AD. In this review, we discuss the functional roles of these genes in synapto-genesis and synaptic functions under physiological conditions, and how their functions are dysregulated in AD. This will provide insights into the contributions of these encoded proteins to synaptic dysfunction during AD pathogenesis.
引用
收藏
页码:3 / 12
页数:10
相关论文
共 50 条
  • [21] Synaptic dysfunction and oxidative stress in Alzheimer's disease: Emerging mechanisms
    Forero, D. A.
    Casadesus, G.
    Perry, G.
    Arboleda, H.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2006, 10 (03) : 796 - 805
  • [22] Coupling of Alzheimer's Disease Genetic Risk Factors with Viral Susceptibility and Inflammation
    Cao, Can
    Fu, Gaoshuang
    Xu, Ruodan
    Li, Ning
    AGING AND DISEASE, 2024, 15 (05): : 2028 - 2050
  • [23] Relationship between genetic risk factors and markers for Alzheimer's disease pathology
    Elias-Sonnenschein, Lyzel S.
    Bertram, Lars
    Visser, Pieter Jelle
    BIOMARKERS IN MEDICINE, 2012, 6 (04) : 477 - 495
  • [24] Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease
    Schott, Jonathan M.
    Crutch, Sebastian J.
    Carrasquillo, Minerva M.
    Uphill, James
    Shakespeare, Tim J.
    Ryan, Natalie S.
    Yong, Keir X.
    Lehmann, Manja
    Ertekin-Taner, Nilufer
    Graff-Radford, Neill R.
    Boeve, Bradley F.
    Murray, Melissa E.
    Khan, Qurat ul Ain
    Petersen, Ronald C.
    Dickson, Dennis W.
    Knopman, David S.
    Rabinovici, Gil D.
    Miller, Bruce L.
    Suarez Gonzalez, Aida
    Gil-Neciga, Eulogio
    Snowden, Julie S.
    Harris, Jenny
    Pickering-Brown, Stuart M.
    Louwersheimer, Eva
    van der Flier, Wiesje M.
    Scheltens, Philip
    Pijnenburg, Yolande A.
    Galasko, Douglas
    Sarazin, Marie
    Dubois, Bruno
    Magnin, Eloi
    Galimberti, Daniela
    Scarpini, Elio
    Cappa, Stefano F.
    Hodges, John R.
    Halliday, Glenda M.
    Bartley, Lauren
    Carrillo, Maria C.
    Brass, Jose T.
    Hardy, John
    Rossor, Martin N.
    Collinge, John
    Fox, Nick C.
    Mead, Simon
    ALZHEIMERS & DEMENTIA, 2016, 12 (08) : 862 - 871
  • [25] Identification of genetic risk factors in the Chinese population implicates a role of immune system in Alzheimer's disease pathogenesis
    Zhou, Xiaopu
    Chen, Yu
    Mok, Kin Y.
    Zhao, Qianhua
    Chen, Keliang
    Chen, Yuewen
    Hardy, John
    Li, Yun
    Fu, Amy K. Y.
    Guo, Qihao
    Ip, Nancy Y.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (08) : 1697 - 1706
  • [26] Synaptic dysfunction in Alzheimer's disease: the effects of amyloid beta on synaptic vesicle dynamics as a novel target for therapeutic intervention
    Marsh, Jade
    Alifragis, Pavlos
    NEURAL REGENERATION RESEARCH, 2018, 13 (04) : 616 - 623
  • [27] Metabotropic Glutamate Receptors in Alzheimer's Disease Synaptic Dysfunction: Therapeutic Opportunities and Hope for the Future
    Srivastava, Akriti
    Das, Brati
    Yao, Annie Y.
    Yan, Riqiang
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 78 (04) : 1345 - 1361
  • [29] Transcriptomics Study of Neurodegenerative Disease: Emphasis on Synaptic Dysfunction Mechanism in Alzheimer's Disease
    Karim, Sajjad
    Mirza, Zeenat
    Ansari, Shakeel A.
    Rasool, Mahmood
    Iqbal, Zafar
    Sohrab, Sayed S.
    Kamal, Mohammad A.
    Abuzenadah, Adel M.
    Al-Qahtani, Mohammed H.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (07) : 1202 - 1212
  • [30] Mitochondrial Dysfunction and Alzheimer's Disease: Role of Microglia
    Agrawal, Ishan
    Jha, Sushmita
    FRONTIERS IN AGING NEUROSCIENCE, 2020, 12